Dow Up0.05% Nasdaq Down0.18%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
118.24 Down 2.15(1.79%) May 5, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Total Revenue 21,192   17,702   18,418   14,602  
Cost of Revenue884  1,250  2,599  1,074  
Gross Profit 20,308   16,452   15,819   13,528  
Operating Expenses
Research Development2,870  2,538  4,010  3,962  
Selling General and Administrative6,188  4,971  7,225  5,994  
Non Recurring234  345  218  223  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 11,016   8,598   4,366   3,349  
Income from Continuing Operations
Total Other Income/Expenses Net(158)3,786  21,767  (450)
Earnings Before Interest And Taxes8,755  10,214  25,263  2,899  
Interest Expense2,927  2,930  2,972  2,973  
Income Before Tax5,828  7,284  22,291  (74)
Income Tax Expense(2,620)(217,255)264  15  
Minority Interest -   -  1,537  843  
Net Income From Continuing Ops11,488  222,369  22,694  754  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 8,448   224,539   23,564   754  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 8,448   224,539   23,564   754  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.